top of page

nadiia has a phd in molecular health from eth, an mba (focus corporate finance) from hsg, and a msc in molecular biology from uni goettingen / max planck.

her life sciences experience includes working with advanced analytics and molecular tools (convolutional neural networks – CNNs; viral vectors: AAV, lentiviruses; bioprocessing, crispr, omics). she previously worked at partners group, kieger, and began her career in bioprocessing with sartorius in 2009.

nadiia is an investor with over 14 years of combined expertise in life sciences and finance. her career spans the entire spectrum of capital markets: sell-side m&a, private equity, and listed equity investments. she invested in large and small companies, with a focus on sub-sectors including medtech, it/tech, tools, cdmo, cro, and pharma/biotech.

experience with advanced analytics and molecular tools

an education from top universities

deep life sciences and finance expertise

investor

"my passion is what i do. i love investing because it is a way for me to give back to the companies and the broader life science ecosystem."

"my passion is what i do. i love investing because it is a way for me to give back to the companies and the broader life science ecosystem."

investment team

+

dr. nadiia wyttenbach

managing director

investor

investment team

+

dr. nadiia wyttenbach

managing director

+

investor

investor

"high-growth companies face unique challenges, and they need knowledgeable and well-connected capital markets. this is why i work."

deep life sciences and finance expertise

experience with advanced analytics and molecular tools

her life sciences experience includes working with advanced analytics and molecular tools (convolutional neural networks – CNNs; viral vectors: AAV, lentiviruses; bioprocessing, crispr, omics). she previously worked at partners group, kieger, and began her career in bioprocessing with sartorius in 2009.

an education from top universities

nadiia is an investor with over 14 years of combined expertise in life sciences and finance. her career spans the entire spectrum of capital markets: sell-side m&a, private equity, and listed equity investments. she invested in large and small companies, with a focus on sub-sectors including medtech, it/tech, tools, cdmo, cro, and pharma/biotech.

nadiia has a phd in molecular health from eth, an mba (focus corporate finance) from hsg, and a msc in molecular biology from uni goettingen / max planck.

bottom of page